Liminatus Pharma Warrants (LIMNW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 86 131 sessions, October 28, 2025 to October 28, 2026
- Largest daily move
- +266.3% close of February 3, 2026
- 1-year change
- -68% closing prices, October 28, 2025 to October 28, 2026
- 1-month change
- -33.2% closing prices, September 23, 2026 to October 28, 2026
Company Description
Liminatus Pharma Warrants (NASDAQ: LIMNW) is classified in the biological products, (no diagnostic substances) industry.
LIMNW declined 68.0% in the 12 months to October 28, 2026. The last closing price was $0.0400.
For FY2025, Liminatus Pharma Warrants reported diluted earnings per share of -$0.43.
This page collects what Stock Titan holds for LIMNW, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Liminatus Pharma Warrants (LIMNW) closed at $0.0400 on October 28, 2026. In the 12 months to October 28, 2026, the price lost 68.0%.
LIMNW Metrics & Rankings
Price returns through October 28, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Liminatus Pharma Warrants has filed 10 recent SEC filings, including 6 Form 8-K, 1 Form 4, 1 Form 10-Q, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LIMNW SEC filings →
Financial Highlights
Liminatus Pharma Warrants reported diluted earnings per share of -$0.43 in FY2025. The current ratio was 0.05, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Liminatus Pharma Warrants (LIMNW) currently stands at 6.6 thousand shares. Since November 2025, short interest has increased by 7331.5%.
Days to Cover History
Days to cover for Liminatus Pharma Warrants (LIMNW) currently stands at 15.0 days, down 66.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 1400%. Across the settlements charted above, it has ranged from 1.0 to 114.0 days.
LIMNW Company Profile & Sector Positioning
Liminatus Pharma Warrants (LIMNW) and is listed on the NASDAQ.